✦ LIBER ✦

209. Synchronous and metachronous bilateral breast cancer -a comparison of clinical, histopathological features of the first and second primary breast cancer and BRCA 1 and 2 mutations

✍ Scribed by E. Nowicka; J. Rogozińska; E. Grzybowska; K. Behrendt; A. Mucha-Małecka; R. Tarnawski

Publisher: Wielkopolskie Centrum Onkologii
Year: 2003
Tongue: Polish
Weight: 107 KB
Volume: 8
Category: Article
ISSN: 1507-1367
DOI: 10.1016/s1507-1367(03)70693-2

No coin nor oath required. For personal study only.

✦ Synopsis

nawet na dfugoletnie przezycie. Czynniki prognostyczne analizowane w pracy nie wykazafy znamiennego statystycznie wpfywu na czas przezycia. Nadal brak scisfych kryteri6w kwalifikacji do zabiegu zmusza chirurga do indywidualnej oceny kazdego przypadku i wyboru maksymalnej korzysci dla pacjenta przy jak najmniejszym ryzyku i uciqzliwosci leczenia.

📜 SIMILAR VOLUMES

231. Synchronous and metachronous bilate

231. Synchronous and metachronous bilateral breast cancer – A comparison of clinical, histopathological features of the first and second primary breast cancer and BRCA 1 and 2 mutations

✍ E. Nowicka; J. Rogozińska; E. Grzybowska; K. Behrendt; A. Mucha-Małecka; R. Tarn 📂 Article 📅 2003 🏛 Wielkopolskie Centrum Onkologii 🌐 Polish ⚖ 187 KB

Frequency of BRCA1 and BRCA2 mutations i

Frequency of BRCA1 and BRCA2 mutations in a clinic-based series of breast and ovarian cancer families

✍ Susan A.J. Vaziri; Lisa M. Krumroy; Majid Rostai; Graham Casey 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 29 KB 👁 2 views

BRCA1/BRCA2mutation status and clinical-

BRCA1/BRCA2mutation status and clinical-pathologic features of 108 male breast cancer cases from Tuscany: a population-based study in central Italy

✍ Laura Ottini; Piera Rizzolo; Ines Zanna; Mario Falchetti; Giovanna Masala; Ketty 📂 Article 📅 2008 🏛 Springer US 🌐 English ⚖ 437 KB

Contribution of BRCA1 and BRCA2 germ-lin

Contribution of BRCA1 and BRCA2 germ-line mutations to the incidence of breast cancer in young women: Results from a prospective population-based study in France

✍ Valerie Bonadona; Olga M. Sinilnikova; Sandrine Chopin; Antonis C. Antoniou; Her 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 154 KB 👁 2 views

## Abstract The prevalence of __BRCA1/2__ germ‐line mutations was assessed in a prospective population‐based series of early‐onset breast cancer (BC) patients in France, and the usefulness of a clinical assessment of hereditary BC risk, based on multiple criteria including pedigree structure, was e

Results of the first phase 1 clinical tr

Results of the first phase 1 clinical trial of the HER-2/neu peptide (GP2) vaccine in disease-free breast cancer patients : United States Military Cancer Institute Clinical Trials Group Study I-04

✍ Mark G. Carmichael; Linda C. Benavides; Jarrod P. Holmes; Jeremy D. Gates; Eliza 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 424 KB 👁 1 views